Literature DB >> 17429639

Nephrotic syndrome as a clinical manifestation of systemic sclerosis.

Ewa Wielosz1, Maria Majdan, Dorota Suszek, Iwona Smarz-Widelska, Agnieszka Korolczuk, Elzbieta Korobowicz.   

Abstract

We have described the unusual case of coexistence of membranous nephropathy resulting in nephrotic syndrome with systemic sclerosis. A 60-year-old patient was admitted to the Department of Nephrology with marked proteinuria and oedema. The renal biopsy specimen disclosed the features characteristic of membranous glomerulonephritis. The patient was treated with chlorambucil for 1 month followed by prednisone for 1 month. However, her condition still did not improve. Therefore, the other causes of nephrotic syndrome were investigated. Once anti-Scl-70 antibody was detected the patient was transferred to the Department of Rheumatology and Connective Tissue Diseases. Physical examination revealed Raynaud phenomenon, sclerodactylia, thickened skin of the chest and back. The patient was diagnosed with diffuse systemic sclerosis. The cyclophosphamide therapy was instituted and the patient's condition improved.

Entities:  

Mesh:

Year:  2007        PMID: 17429639     DOI: 10.1007/s00296-007-0340-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  7 in total

1.  Renal and cerebral scleroderma.

Authors:  F M BOURNE; D A HOWELL; H S ROOT
Journal:  Can Med Assoc J       Date:  1960-04-23       Impact factor: 8.262

2.  [Progressive systemic sclerosis sine scleroderma with nephrotic syndrome and suspected renal tubular acidosis (author's transl)].

Authors:  Y Kobayashi; M Muraoka; T Tojo; T Abe; M Homma; T Kawai; Y Hosoda
Journal:  Nihon Naika Gakkai Zasshi       Date:  1977-02-10

3.  Kidney disease other than renal crisis in patients with diffuse scleroderma.

Authors:  Virginia D Steen; Aijaz Syzd; John P Johnson; Arthur Greenberg; Thomas A Medsger
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

4.  Secondary membranous nephropathy--one center experience.

Authors:  Zuzana Rihova; Eva Honsova; Miroslav Merta; Eva Jancova; Romana Rysava; Jana Reiterova; Jiri Zabka; Vladimir Tesar
Journal:  Ren Fail       Date:  2005       Impact factor: 2.606

Review 5.  Therapy of membranous nephropathy associated with malignancy and secondary causes.

Authors:  J Ashley Jefferson; William G Couser
Journal:  Semin Nephrol       Date:  2003-07       Impact factor: 5.299

6.  Progressive systemic sclerosis and nephrotic syndrome. An unusual association resulting in postpartum acute renal failure.

Authors:  A Palma; A Sanchez-Palencia; J R Armas; J A Milan; J Fernandez-Sanz; F Llach
Journal:  Arch Intern Med       Date:  1981-03

7.  Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases.

Authors:  Y M Traub; A P Shapiro; G P Rodnan; T A Medsger; R H McDonald; V D Steen; T A Osial; S F Tolchin
Journal:  Medicine (Baltimore)       Date:  1983-11       Impact factor: 1.889

  7 in total
  4 in total

1.  Long-term follow-up after nonmyeloablative allogeneic hematopoietic stem cell transplantation for systemic sclerosis.

Authors:  Motoaki Shiratsuchi; Seiichi Motomura; Yasunobu Abe; Satoshi Shiokawa; Junji Nishimura
Journal:  Clin Rheumatol       Date:  2008-05-16       Impact factor: 2.980

2.  Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis.

Authors:  Ewa Wielosz; Magdalena Dryglewska; Maria Majdan
Journal:  Clin Rheumatol       Date:  2009-05-13       Impact factor: 2.980

3.  Patterns of renal pathology in Chinese patients with systemic sclerosis undergoing renal biopsy at a tertiary medical center.

Authors:  Xiao-Yu Cao; He Liu; Dong Xu; Meng-Tao Li; Qian Wang; Li Jiang; Yong Hou; Li-Xiu Zhu; Xiao-Feng Zeng
Journal:  J Int Med Res       Date:  2019-12-27       Impact factor: 1.671

Review 4.  How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy.

Authors:  Tiffany N Caza; Laith F Al-Rabadi; Laurence H Beck
Journal:  Front Immunol       Date:  2021-11-26       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.